Alcidion's New Contract Improves U.K. Credibility -- Market Talk

Dow Jones

May 26

0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.K., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

May 25, 2026 21:34 ET (01:34 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2638569006"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2638569006\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2638569006?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 09:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638569006","market":"sg","top_or_hot":-1,"title":"Alcidion's New Contract Improves U.K. Credibility -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 25, 2026 21:34 ET (01:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alcidion's New Contract Improves U.K. Credibility -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlcidion's New Contract Improves U.K. Credibility -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-26 09:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 25, 2026 21:34 ET (01:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7094","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2638569006","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638569006","pubTimestamp":1779759240,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.K., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7094":"医疗保健技术","ALC.AU":"ALCIDION GROUP LTD"},"translate_title":"Alcidion的新合同提高了英国的可信度——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALC.AU":0.9},"content_text":"0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.K., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 25, 2026 21:34 ET (01:34 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}